◎Not
Verified
Registered — Not Verified
Rapamycin
Rapamycin is an FDA-approved immunosuppressive drug that inhibits the mTOR (mechanistic target of rapamycin) signaling pathway, originally used to prevent organ transplant rejection and now being studied for anti-aging effects.
Updated May 22, 2026
◎
Unverified Profile
This profile is based on publicly available data and has not yet been independently verified by Elivion. Verified profiles include in-depth evidence analysis, safety data, and clinical insights.
🔒
Requires verificationEvidence Summary
🔒
Requires verificationHow it Works
🔒
Requires verificationClinical Applications
🔒
Requires verificationKey Studies
🔒
Requires verificationSafety & Contraindications
🔒
Requires verificationWhat We Still Don't Know
🔒
Requires verificationFrequently Asked Questions
Represent this treatment?
Claim & verify this profile →